Lifecore Biomedical
LFCR
109 hedge funds and large institutions have $338M invested in Lifecore Biomedical in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 48 reducing their positions, and 10 closing their positions.
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
13% more capital invested
Capital invested by funds: $301M → $338M (+$37.8M)
2% more funds holding
Funds holding: 107 → 109 (+2)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
42% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 48
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$6.16M |
| 2 |
RA
Royce & Associates
New York
|
+$5.49M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$4.67M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.29M |
| 5 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
+$1.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$6.97M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$3.51M |
| 3 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
-$2.7M |
| 4 |
ACM
Argent Capital Management
St Louis,
Missouri
|
-$1.8M |
| 5 |
SCM
Summit Capital Management
Seattle,
Washington
|
-$1.41M |
LFCR Hedge Fund Activity: Q4 2014 in Review
109 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q4 2014, worth a combined $338M — up 13% from $301M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new LFCR positions and 10 closed out — a net gain of 4 holders — while 28 added to existing stakes and 48 trimmed.
The largest buyer was NWQ Investment Management Company, adding an estimated $6.16M. The largest seller was Guggenheim Capital, cutting an estimated $6.97M.
- 109 institutional investors held Lifecore Biomedical (LFCR) as of Q4 2014, up from 107 in Q3 2014.
- Funds reported $338M of Lifecore Biomedical stock for Q4 2014, up 13% quarter-over-quarter.
- 14 funds opened new Lifecore Biomedical positions in Q4 2014 and 10 closed out, a net change of +4 holders.
- The largest Lifecore Biomedical buyer in Q4 2014 was NWQ Investment Management Company, an estimated $6.16M added.
- The largest Lifecore Biomedical seller in Q4 2014 was Guggenheim Capital, an estimated $6.97M sold.
Based on aggregated 13F filings for Q4 2014.